ARID1A-deficient cells promote endometrial carcinoma progression and dissemination by reprograming tumor microenvironment.
C. Megino, X. Matias-Guiu, N. Eritja
This study shows ARID1A-deficient endometrial tumor cells reprogram the tumor microenvironment, promoting cancer progression and dissemination through chemokine secretion.
bioRxiv · Dec 14, 2022 · PreprintCancer Biology